Shares of Agilent Technologies, Inc. (NYSE:A – Get Free Report) have earned an average rating of “Moderate Buy” from the fourteen research firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $144.36.
Several equities research analysts have recently commented on the company. Citigroup upped their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Stifel Nicolaus reaffirmed a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research note on Monday, August 26th. TD Cowen lifted their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Evercore ISI upped their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Finally, Barclays raised their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 15th.
Get Our Latest Stock Analysis on Agilent Technologies
Insider Activity at Agilent Technologies
Hedge Funds Weigh In On Agilent Technologies
A number of institutional investors have recently modified their holdings of the company. Crewe Advisors LLC boosted its stake in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies in the third quarter valued at approximately $28,000. Ridgewood Investments LLC acquired a new stake in shares of Agilent Technologies in the second quarter worth $29,000. Fortitude Family Office LLC increased its position in Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after acquiring an additional 95 shares during the period. Finally, Ashton Thomas Private Wealth LLC acquired a new position in Agilent Technologies during the 2nd quarter valued at $39,000. Institutional investors own 87.42% of the company’s stock.
Agilent Technologies Stock Performance
Shares of A opened at $130.19 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The firm’s 50 day moving average is $140.72 and its 200-day moving average is $138.53. Agilent Technologies has a 12-month low of $96.80 and a 12-month high of $155.35. The stock has a market capitalization of $37.98 billion, a P/E ratio of 30.78, a P/E/G ratio of 6.96 and a beta of 1.05.
Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the business posted $1.43 earnings per share. The firm’s quarterly revenue was down 5.6% compared to the same quarter last year. Equities research analysts anticipate that Agilent Technologies will post 5.24 EPS for the current fiscal year.
Agilent Technologies Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were paid a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
- Five stocks we like better than Agilent Technologies
- Conference Calls and Individual Investors
- Texas Roadhouse Stock Steering for New Highs This Year
- Are Penny Stocks a Good Fit for Your Portfolio?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What Are Dividend Contenders? Investing in Dividend Contenders
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.